Want to see DE:HPHA full AI Analyst Report?
Heidelberg Pharma AG (HPHA) Ratios
Heidelberg Pharma AG Ratios
DE:HPHA's free cash flow for Q3 2026 was $-5.05M. For the 2026 fiscal year, DE:HPHA's free cash flow was decreased by $-2.88K and operating cash flow was $-5.05M. See a summary of the company’s cash flow.
| Ratios | Feb 26 | Feb 25 | Feb 24 | Feb 23 | Feb 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.53 | 5.95 | 2.86 | 3.15 | 0.60 |
| Quick Ratio | 1.58 | 4.47 | 2.33 | 2.98 | 0.55 |
| Cash Ratio | 1.34 | 3.68 | 2.20 | 2.91 | 0.41 |
| Solvency Ratio | -0.80 | -0.62 | -0.93 | -0.56 | -1.72 |
| Operating Cash Flow Ratio | -2.82 | -3.70 | -1.70 | -0.32 | -1.78 |
| Short-Term Operating Cash Flow Coverage | -310.49 | -256.29 | -5.96 | -0.56 | -2.54 |
| Net Current Asset Value | $ -20.72M | $ 17.71M | $ 35.62M | $ 53.94M | $ -6.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.36 | 0.08 | 0.16 | 0.49 |
| Debt-to-Equity Ratio | -0.11 | 0.71 | 0.12 | 0.24 | 1.59 |
| Debt-to-Capital Ratio | -0.12 | 0.42 | 0.11 | 0.19 | 0.61 |
| Long-Term Debt-to-Capital Ratio | -0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -3.49 | 1.97 | 1.43 | 1.51 | 3.24 |
| Debt Service Coverage Ratio | -428.12 | -71.49 | -2.92 | -1.09 | -2.31 |
| Interest Coverage Ratio | -9656.78 | -173.56 | -27.85 | -21.83 | -51.88 |
| Debt to Market Cap | 0.01 | 0.00 | 0.04 | 0.07 | 0.06 |
| Interest Debt Per Share | 0.03 | 0.47 | 0.14 | 0.45 | 0.34 |
| Net Debt to EBITDA | 0.31 | 0.41 | 2.01 | 4.04 | -0.18 |
| Profitability Margins | |||||
| Gross Profit Margin | -81.41% | 61.29% | 67.01% | 74.73% | -169.29% |
| EBIT Margin | -3255.36% | -280.91% | -198.65% | -91.53% | -1465.55% |
| EBITDA Margin | -3062.01% | -268.19% | -189.74% | -87.45% | -1418.89% |
| Operating Profit Margin | -3255.36% | -358.55% | -215.13% | -99.03% | -1464.78% |
| Pretax Profit Margin | -2829.08% | -282.98% | -206.38% | -96.07% | -1493.79% |
| Net Profit Margin | -2901.15% | -282.98% | -206.38% | -106.42% | -1522.05% |
| Continuous Operations Profit Margin | -2901.15% | -282.98% | -206.38% | -106.42% | -1493.79% |
| Net Income Per EBT | 102.55% | 100.00% | 100.00% | 110.77% | 101.89% |
| EBT Per EBIT | 86.91% | 78.92% | 95.93% | 97.01% | 101.98% |
| Return on Assets (ROA) | -110.87% | -31.92% | -28.92% | -19.59% | -122.55% |
| Return on Equity (ROE) | 387.26% | -62.79% | -41.24% | -29.56% | -397.59% |
| Return on Capital Employed (ROCE) | -176.20% | -46.58% | -41.93% | -25.24% | -377.09% |
| Return on Invested Capital (ROIC) | -175.53% | -46.38% | -37.65% | -20.71% | -147.70% |
| Return on Tangible Assets | -144.27% | -37.37% | -33.11% | -21.50% | -209.38% |
| Earnings Yield | -31.46% | -17.33% | -15.82% | -9.25% | -15.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.62 | 1.15 | 6.67 | 12.75 | 1.72 |
| Payables Turnover | 0.37 | 0.32 | 0.41 | 1.70 | 5.22 |
| Inventory Turnover | 0.25 | 0.15 | 0.31 | 1.02 | 6.32 |
| Fixed Asset Turnover | 1.60 | 1.96 | 2.56 | 4.94 | 0.47 |
| Asset Turnover | 0.04 | 0.11 | 0.14 | 0.18 | 0.08 |
| Working Capital Turnover Ratio | 0.05 | 0.18 | 0.20 | 0.69 | -0.70 |
| Cash Conversion Cycle | 1063.30 | 1602.09 | 347.84 | 171.26 | 200.54 |
| Days of Sales Outstanding | 587.66 | 317.24 | 54.68 | 28.63 | 212.71 |
| Days of Inventory Outstanding | 1464.68 | 2422.37 | 1176.84 | 357.64 | 57.78 |
| Days of Payables Outstanding | 989.04 | 1137.53 | 883.68 | 215.02 | 69.95 |
| Operating Cycle | 2052.34 | 2739.61 | 1231.52 | 386.28 | 270.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.68 | -0.63 | -0.72 | -0.24 | -0.82 |
| Free Cash Flow Per Share | -0.68 | -0.64 | -0.74 | -0.25 | -0.86 |
| Dividend Paid and CapEx Coverage Ratio | -245.62 | -64.88 | -35.08 | -14.46 | -19.16 |
| Capital Expenditure Coverage Ratio | -245.62 | -64.88 | -35.08 | -14.46 | -19.16 |
| Operating Cash Flow Coverage Ratio | -27.13 | -1.35 | -5.77 | -0.55 | -2.50 |
| Operating Cash Flow to Sales Ratio | -21.68 | -4.32 | -3.42 | -0.48 | -15.21 |
| Free Cash Flow Yield | -23.61% | -26.86% | -26.93% | -4.45% | -16.63% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.16 | -5.77 | -6.32 | -10.81 | -6.32 |
| Price-to-Sales (P/S) Ratio | 92.22 | 16.33 | 13.04 | 11.50 | 96.22 |
| Price-to-Book (P/B) Ratio | -12.31 | 3.62 | 2.61 | 3.20 | 25.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.24 | -3.72 | -3.71 | -22.47 | -6.01 |
| Price-to-Operating Cash Flow Ratio | -4.25 | -3.78 | -3.82 | -24.03 | -6.33 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | 1.27 | 0.37 | 0.31 | -0.18 |
| Enterprise Value Multiple | -2.70 | -5.68 | -4.86 | -9.12 | -6.96 |
| Enterprise Value | 120.59M | 104.40M | 91.00M | 147.64M | 172.86M |
| EV to EBITDA | -2.70 | -5.68 | -4.86 | -9.12 | -6.96 |
| EV to Sales | 82.75 | 15.24 | 9.23 | 7.97 | 98.79 |
| EV to Free Cash Flow | -3.80 | -3.48 | -2.63 | -15.58 | -6.17 |
| EV to Operating Cash Flow | -3.82 | -3.53 | -2.70 | -16.66 | -6.50 |
| Tangible Book Value Per Share | -0.42 | 0.47 | 0.87 | 1.55 | -0.07 |
| Shareholders’ Equity Per Share | -0.23 | 0.66 | 1.06 | 1.79 | 0.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.03 | 0.00 | 0.00 | -0.11 | -0.02 |
| Revenue Per Share | 0.03 | 0.15 | 0.21 | 0.50 | 0.05 |
| Net Income Per Share | -0.91 | -0.42 | -0.44 | -0.53 | -0.82 |
| Tax Burden | 1.03 | 1.00 | 1.00 | 1.11 | 1.02 |
| Interest Burden | 0.87 | 1.01 | 1.04 | 1.05 | 1.02 |
| Research & Development to Revenue | 26.61 | 3.19 | 2.85 | 1.42 | 10.72 |
| SG&A to Revenue | 5.22 | 1.19 | 0.53 | 0.26 | 2.28 |
| Stock-Based Compensation to Revenue | 0.08 | 0.00 | 0.10 | 0.03 | 0.39 |
| Income Quality | 0.75 | 1.53 | 1.65 | 0.45 | 1.02 |
Currency in EUR
